2025 fourth_quarter Filing
Q4Lobbying Activities
Reshoring API critical inputs and the generic drug supply chain to address shortages and drug safety issues due to foreign reliance; Producing Incentives for Long-term production of Lifesaving Supply of Medicine Act (PILLS Act); Other measures to strengthen the domestic pharmaceutical supply chain.
FY26 Appropriations affecting domestic manufacturing